Science Applications International Corp
For the period ended May 2, 2025. Filed Jun 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
May 2, 2025 · Filed Jun 2, 2025
SAIC$152.53+1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
SCIENCE APPLICATIONS INTERNATIONAL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
| Three Months Ended | ||
|---|---|---|
| May 2,2025 | May 3,2024 | |
| (in millions) | ||
| Cash flows from operating activities: | ||
| Net income | $68 | $77 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 36 | 35 |
| Stock-based compensation expense | 15 | 13 |
| Other | — | (1) |
| Increase (decrease) resulting from changes in operating assets and liabilities: | ||
| Receivables | (9) | (20) |
| Prepaid expenses and other current assets | 6 | 15 |
| Accounts payable and accrued liabilities | 33 | 60 |
| Accrued payroll and employee benefits | (51) | (83) |
| Operating lease assets and liabilities, net | (2) | (3) |
| Other assets and other long-term liabilities, net | 4 | 5 |
| Net cash provided by operating activities | 100 | 98 |
| Cash flows from investing activities: | ||
| Expenditures for property, plant, and equipment | (8) | (6) |
| Purchases of marketable securities | (4) | (4) |
| Sales of marketable securities | 3 | 4 |
| Contributions to investments | (6) | (1) |
| Net cash used in investing activities | (15) | (7) |
| Cash flows from financing activities: | ||
| Principal payments on borrowings | (689) | (310) |
| Proceeds from borrowings | 750 | 293 |
| Stock repurchased and retired or withheld for taxes on equity awards | (142) | (103) |
| Dividend payments to stockholders | (19) | (20) |
| Issuances of stock | 6 | 4 |
| Net cash used in financing activities | (94) | (136) |
| Net decrease in cash, cash equivalents and restricted cash | (9) | (45) |
| Cash, cash equivalents and restricted cash at beginning of period | 64 | 103 |
| Cash, cash equivalents and restricted cash at end of period | $55 | $58 |
-5-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.